CD38 and Stroke: In stroke models induced by focal cerebral ischemia and reperfusion, CD38-deficient mice showed decreased local expression of the proinflammatory chemokine MCP-1, reduced populations of infiltrating macrophages and lymphocytes in the ischemic hemisphere, and, more importantly, reduced cerebral ischemic injury and neurological deficit after three days of reperfusion [62].